{
    "code": "56030469",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56030469",
    "time": "2023-01-27 05:28:24",
    "許可證字號": "衛部醫器輸字第030469號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD3138",
    "有效日期": "111\/12\/04",
    "發證日期": "106\/12\/04",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05603046900",
    "中文品名": "亞培凡若西愛滋病毒基因分型系統",
    "英文品名": "Abbott ViroSeq HIV-1 Genotyping System",
    "效能": "本產品是用來偵測人類免疫缺乏病毒(HIV)之基因突變，而能對照出病人身上的病毒是否已產生特異性針對某些抗反轉錄病毒藥物的抗藥性，以幫助HIV感染之監控與治療。亞培凡若喜愛滋病毒基因分型系統可用於:\r\n1.\t從使用EDTA作為抗凝劑所收集到的血漿檢體中偵測HIV-1B亞型病毒的抗藥性，其病毒負荷量偵測範圍為2,000到75,000複製數\/毫升(copies\/mL)。\r\n2.\t將HIV-1整個蛋白酶基因(protease gene)的第1到第99個密碼子，與三分之二個反轉錄酶基因(reverse transcriptase gene, RT)的第1到第335個密碼子，進行基因分型。",
    "醫器規格": "1.4J94-93 ViroSeq HIV-1 Genotyping System v2.0。\r\n2.4J94-23 ViroSeq HIV-1 Genotyping Software v3.0 and Algorithm Advisor。\r\n以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MUS2189400  ABBOTT MOLECULAR INC.",
            "製造廠廠址": "1300 EAST TOUHY AVENUE, DES PLAINES, IL 60018, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560304690001-107-03-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030469&Seq=001&Type=9"
        },
        {
            "title": "560304690002-107-03-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030469&Seq=001&Type=8"
        }
    ]
}